Inadequate response to antiplatelet therapy in Sneddon's syndrome. Time to re-evaluate management recommendations?

被引：0

作者：

Lecaros, Cristobal ^{[1
]}

Coulon, Gabriela ^{[1
]}

Recule, Francisca ^{[1
]}

Castro, Alex ^{[2
]}

Del Puerto, Constanza ^{[1
]}

机构：

[1] Univ Desarrollo, Fac Med, Dept Dermatol, Clin Alemana, Santiago, Chile

[2] Univ Desarrollo, Fac Med, Dept Pathol, Clin Alemana, Santiago, Chile

来源：

ANAIS BRASILEIROS DE DERMATOLOGIA | 2024年 / 99卷 / 05期

关键词：

ANTIBODIES;

D O I：

10.1016/j.abd.2024.01.001

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：780 / 783

页数：4

共 36 条

[21] The Emperor's New Code? Time to Re-Evaluate the Nature of Stewardship Engagement Under the UK's Stewardship Code
Reddy, Bobby, V
MODERN LAW REVIEW, 2021, 84 (04): : 842 - 873
[22] It's time to re-evaluate the reporting of common measures from isokinetic dynamometers: isokinetic for torque, isotonic for power
Thompson, Brennan J.
FRONTIERS IN SPORTS AND ACTIVE LIVING, 2025, 7
[23] The cost (and confidence) in diagnosing Parkinson's disease: Is it time to re-evaluate our continuing medical education strategy?
McLaughlin, K. P.
Siddiqui, J. H.
Ahmed, A.
Cooper, S.
Gostkowski, M.
Itin, I.
Rudolph, J.
Sweeney, P.
Fernandez, H. H.
MOVEMENT DISORDERS, 2012, 27 : S129 - S129
[24] It's high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
Yao, Shiya
Han, Yuejun
Yang, Mengxiang
Jin, Ketao
Lan, Huanrong
FRONTIERS IN IMMUNOLOGY, 2023, 14
[25] Minimally invasive endoscopic therapy for the management of Boerhaave's syndrome RESPONSE
Darrien, J. H.
Kasem, H.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2014, 96 (03) : 254 - 254
[26] Pulmonary Vascular Resistance Is Not an Independent Predictor of Post-Transplant Outcome in Bridge-to-Transplant Patients; It's Time to Re-Evaluate Our Current Heart Transplant Eligibility
Ando, M.
Takeda, K.
Kurlansky, P. A.
Wright, M.
Lee, C.
Han, J.
Garan, A. R.
Topkara, V. K.
Yuzefpolskaya, M.
Colombo, P. C.
Farr, M.
Naka, Y.
Takayama, H.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S232 - S232
[27] Response to: Comment on 'Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes' by Kerimoglu et al.: Cetrorelix in COH cycles: time to re-evaluate the daily administered dose?
Kerimoglu, Ozlem Secilmis
Ercan, Cihangir Mutlu
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 289 (04) : 701 - 702
[28] Author's response to the letter on the article: "Oral cobalamin therapy: It may be perhaps time to propose international recommendations?"
Andres, Emmanuel
PRESSE MEDICALE, 2013, 42 (02): : 241 - 242
[29] Response to: Comment on ‘Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes’ by Kerimoğlu et al.: Cetrorelix in COH cycles: time to re-evaluate the daily administered dose?
Ozlem Secilmis Kerimoğlu
Cihangir Mutlu Ercan
Archives of Gynecology and Obstetrics, 2014, 289 : 701 - 702
[30] Time to re-evaluate antimicrobial agents in an era of increasing resistance -: Proceedings of an integrated symposium held at the 12th European Congress of Clinical Microbiology and Infectious Diseases -: Milan, April 2002 -: Chairman's comments -: Introduction
Pechère, JC
CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 : V - V

← 1 2 3 4 →